ChemoCentryx, Inc. Insider Trading for February 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ChemoCentryx, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ChemoCentryx, Inc. for February 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 14.31 | 15,341 | 219,530 | 286,882 | |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 14.31 | 63,340 | 906,395 | 302,223 | |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 51.10 | 29 | 1,482 | 2,268,557 | 2.3 M to 2.3 M (0.00 %) |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 50.21 | 15,312 | 768,814 | 2,268,586 | 2.3 M to 2.3 M (-0.67 %) |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 14.31 | 15,341 | 219,530 | 2,283,898 | 2.3 M to 2.3 M (+0.68 %) |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 51.14 | 7,723 | 394,977 | 2,268,557 | 2.3 M to 2.3 M (-0.34 %) |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 50.41 | 55,617 | 2,803,536 | 2,276,280 | 2.3 M to 2.3 M (-2.39 %) |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 14.31 | 63,340 | 906,395 | 2,331,897 | 2.3 M to 2.3 M (+2.79 %) |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 10.86 | 24,200 | 262,812 | 55,000 | |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 50.63 | 3,200 | 162,013 | 94,180 | 97.4 K to 94.2 K (-3.29 %) |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 50.06 | 21,000 | 1,051,208 | 97,380 | 118.4 K to 97.4 K (-17.74 %) |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 10.86 | 24,200 | 262,812 | 118,380 | 94.2 K to 118.4 K (+25.70 %) |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 8.19 | 42,631 | 349,148 | 0 | |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 50.99 | 1,163 | 59,306 | 76,247 | 77.4 K to 76.2 K (-1.50 %) |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 50.34 | 41,468 | 2,087,391 | 77,410 | 118.9 K to 77.4 K (-34.88 %) |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 8.19 | 42,631 | 349,148 | 118,878 | 76.2 K to 118.9 K (+55.91 %) |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 10.86 | 26,600 | 288,876 | 79,200 | |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 10.86 | 1,400 | 15,204 | 105,800 | |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 10.86 | 2,800 | 30,408 | 107,200 | |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 8.19 | 18,700 | 153,153 | 172,132 | |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 8.19 | 1,100 | 9,009 | 190,832 | |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 8.19 | 200 | 1,638 | 191,932 | |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 49.61 | 45,300 | 2,247,147 | 94,180 | 139.5 K to 94.2 K (-32.48 %) |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 10.86 | 26,600 | 288,876 | 139,480 | 112.9 K to 139.5 K (+23.56 %) |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 8.19 | 18,700 | 153,153 | 112,880 | 94.2 K to 112.9 K (+19.86 %) |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 49.51 | 2,500 | 123,776 | 94,180 | 96.7 K to 94.2 K (-2.59 %) |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 10.86 | 1,400 | 15,204 | 96,680 | 95.3 K to 96.7 K (+1.47 %) |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 8.19 | 1,100 | 9,009 | 95,280 | 94.2 K to 95.3 K (+1.17 %) |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 49.50 | 3,000 | 148,510 | 94,180 | 97.2 K to 94.2 K (-3.09 %) |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 10.86 | 2,800 | 30,408 | 97,180 | 94.4 K to 97.2 K (+2.97 %) |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 8.19 | 200 | 1,638 | 94,380 | 94.2 K to 94.4 K (+0.21 %) |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Sell | S | 49.15 | 18,941 | 930,888 | 493 | 19.4 K to 493 (-97.46 %) |
Feb 10 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 8.19 | 36,850 | 301,802 | 42,901 | |
Feb 10 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 47.31 | 36,850 | 1,743,340 | 76,247 | 113.1 K to 76.2 K (-32.58 %) |
Feb 10 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 8.19 | 36,850 | 301,802 | 113,097 | 76.2 K to 113.1 K (+48.33 %) |
Feb 06 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 14.31 | 119,525 | 1,710,403 | 365,563 | |
Feb 06 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 45.18 | 119,525 | 5,400,701 | 2,268,557 | 2.4 M to 2.3 M (-5.01 %) |
Feb 06 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 14.31 | 119,525 | 1,710,403 | 2,388,082 | 2.3 M to 2.4 M (+5.27 %) |
Feb 05 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 14.31 | 99,617 | 1,425,519 | 0 | |
Feb 05 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 14.31 | 3,837 | 54,907 | 99,617 | |
Feb 05 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 45.10 | 99,617 | 4,492,229 | 94,180 | 193.8 K to 94.2 K (-51.40 %) |
Feb 05 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 14.31 | 99,617 | 1,425,519 | 193,797 | 94.2 K to 193.8 K (+105.77 %) |
Feb 05 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 44.91 | 3,837 | 172,317 | 94,180 | 98 K to 94.2 K (-3.91 %) |
Feb 05 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 14.31 | 3,837 | 54,907 | 98,017 | 94.2 K to 98 K (+4.07 %) |
Feb 05 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 8.19 | 13,150 | 107,699 | 79,751 | |
Feb 05 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 8.19 | 48,471 | 396,977 | 92,901 | |
Feb 05 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 47.03 | 13,150 | 618,451 | 76,427 | 89.6 K to 76.4 K (-14.68 %) |
Feb 05 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 8.19 | 13,150 | 107,699 | 89,397 | 76.2 K to 89.4 K (+17.25 %) |
Feb 05 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 44.47 | 48,471 | 2,155,525 | 76,247 | 124.7 K to 76.2 K (-38.86 %) |
Feb 05 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 8.19 | 48,471 | 396,977 | 124,718 | 76.2 K to 124.7 K (+63.57 %) |